Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Abexxa Biologics is a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology to develop the next generation of precision medicine. Abexxa is focused on developing novel therapeutics around its newly discovered class of intracellular antigens (atypical HLA-peptide complexes) on cancerous cells. These atypical HLA-peptide complexes provide access to previously un-druggable targets and have ...
Abexxa Biologics is a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology to develop the next generation of precision medicine. Abexxa is focused on developing novel therapeutics around its newly discovered class of intracellular antigens (atypical HLA-peptide complexes) on cancerous cells. These atypical HLA-peptide complexes provide access to previously un-druggable targets and have been shown to play a regulatory role in modulating innate and adaptive immune responses.

List your booth number for exhibitions, ask us